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Fulfillment of the promise of genomic medicine rests, in 
part, on the development of a trained workforce, including 
laboratory technicians and directors, genetic counselors, 
pharmacists, and clinicians, as well as increased scientific 
literacy among the public. Substantial need to identify ef-
fective methods to teach about genetic testing and genome 
sequencing has prompted interest in using “hands-on” 
testing/sequencing of students’ own genomes in second-
ary-school classrooms, college courses, and professional 
schools (13, 25). Supporting employment of this hands-on 
approach are studies showing that college students are 
more likely to enroll in a course offering personal DNA 
testing and that they find the course more interesting and 
the material easier to grasp when personalized in this way 
(4). Seventy percent of Stanford medical students having 
personal genetic testing as part of their curriculum, for 
example, believed that it enhanced their understanding of 
human genetics (19). Undergoing testing and using personal 
data in class exercises were found to enhance self-reported 
and assessed learning. Given such reports of educational 
benefit, a growing interest in courses incorporating such 
testing (1), and the rapidly decreasing cost of genome 
sequencing (14), there is—and should be—increased at-
tention to the ethical issues associated with incorporating 
personal genomic testing/sequencing into curricula (3, 17). 
This paper examines the types and technologies of testing 
and the particular issues raised by each; issues specific to 
the educational context; issues of privacy (including risks 
of discrimination and stigmatization); issues surrounding 
the right to know/not-know personal information; and 
subtle psychosocial sequelae of learning personal genomic 
information. In addition, the paper both proposes measures 
to mitigate ethical concerns associated with the curricular 
use of personal genomic testing/sequencing and suggests 
how classroom discussion of these ethical concerns can 
be used to prompt consideration of ethical issues related 
to research design and conduct.
ISSUES ASSOCIATED WITH PARTICULAR TECHNOLOGIES
Chromosomal analysis (karyotyping) of one’s own blood 
is a long-standing classroom exercise. Students and teachers 
have long needed to be prepared to address the unexpected 
discovery of an abnormal karyotype; for example, a female 
student’s rare discovery that she has a 46,XY karyotype 
indicating that she has complete androgen insensitivity 
syndrome, is sterile, and may need evaluation for cancer 
risk. Her discovery would explain her amenorrhea, but is a 
discovery better made under the care of a physician, not in 
high-school biology class. Similarly, chromosomal analysis 
may reveal a balanced translocation (with relevance for re-
productive planning), chromosomal inversion (of potential 
relevance to fertility), or mosaicism of sex chromosomes 
(e.g., 46,XY/47,XXY mosaicism resulting in a rare, mild, 
and frequently undiagnosed form of Klinefelter syndrome). 
Educators asking students to karyotype their own chromo-
somes should be prepared to refer students to appropriate 
physicians or genetic counselors and should discuss the 
privacy of health-related information including karyotypes, 
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as unthinking self-disclosure is a primary risk to the privacy 
of health-related information. 
Genetic testing reveals variations in the DNA that are 
associated with a range of traits including eye color, (in)ability 
to taste bitterness, continental ancestry, alcohol tolerance, 
and disease risk. How genetic testing is actually performed 
for classroom use varies. Sending student samples for 
analysis by commercial direct-to-consumer companies fails 
to provide students with hands-on experience in laboratory 
techniques (e.g., DNA extraction and amplification) that they 
may gain by running polymerase chain reactions on their own 
DNA. In-class genotyping to identify polymorphisms may 
focus on DNA fingerprinting or identification exercises, or 
on analysis of genes associated with traits or disease condi-
tions. The latter borders on—and may constitute—medical 
testing, which raises issues about quality control and the 
(likely) failure to conduct the test in a laboratory certified 
under the Clinical Laboratory Improvement Amendments 
(CLIA certification), as well as the ethical concerns arising 
with any medical test: e.g., informed consent, appropriate 
use of test results, and privacy protection. Attempting to 
avoid these concerns, educators may avoid testing exercises 
focused on disease-associated genes, particularly when stu-
dents analyze their own genes and/or access their own test 
results. Educators may instead focus on obvious phenotypic 
traits (e.g., eye color) or non-deleterious variations like 
the PTC gene, TAS2R38, that codes for a taste receptor 
enabling or preventing people from tasting phenylthiocar-
bamide (PTC), a bitter-tasting compound. Nevertheless, it 
must be remembered that pleiotropy, whereby one gene 
can influence more than one phenotypic trait, can result in 
seemingly benign findings acquiring health-related import 
as knowledge of genetics grows.
Particularly if the class is large enough, another ap-
proach is to treat the class as a population with the students’ 
individual test results forming an aggregate data set for 
further study. The students can test their own DNA; those 
who prefer not to can be supplied with alternate samples. 
With this approach, focusing on disease-related polymor-
phisms might be deemed less problematic if individual test-
ing is done anonymously (i.e., with no results returnable to 
individuals). Commentators expressed concern about one 
classroom exercise employing anonymous testing (21), both 
that “several participants could potentially identify their 
results by examining the data, illustrating one disadvantage 
of working with a relatively small sample size,” and that the 
educators did not indicate whether students could, in fact, 
opt out of personal testing and work with other samples 
(18). If the total number of participants is small or if there 
is limited diversity in the sample (e.g., only a few male stu-
dents, or only a few of Asian continental ancestry), a trait 
that segregates with genotypes indicating the minority sex 
or the distinctive continental ancestry may be attributed to 
those few students in the class, raising question about the 
protection of their privacy even if only aggregate data are 
analyzed. Explicit classroom discussion of this concern may 
be used to introduce a broader discussion of how various 
types of research can affect community interests, as well as 
methods of protecting those interests, including community 
consultation or consent (26). 
Whether or not disease-related polymorphisms are 
studied, classroom testing may raise some of the issues 
arising with clinical carrier testing. Knowing patterns 
of inheritance of particular genes, for example, enables 
prediction of the likelihood that the offspring of a genetic 
mother-father pair will inherit a particular gene. Similarly, 
in reverse, knowing inheritance patterns and an individual’s 
genotype can enable estimation (with limited accuracy and 
barring spontaneous mutation) that persons with particular 
genotypes are the individual’s genetic parents. Thus genetic 
testing of mother-father-child trios (unlikely in an educa-
tional context)—or in the case of some traits, knowledge 
of the parents’ phenotypes (likely)—can indicate a student’s 
misattributed parentage (frequently, misattributed pater-
nity, but also previously undisclosed adoption or use of a 
gamete donor). Inheritance patterns can raise questions 
about familial relationships even in the case of presumptively 
neutral traits like bitter taste perception, as the ability to 
taste PTC is a dominant genetic trait (and thus at least one 
parent of a student who can taste PTC should also be able 
to taste it). When planning for and discussing the potential 
for such discoveries through classroom testing, instructors 
may explore the research ethics issue of managing incidental 
findings that arise in multiple research domains (28). 
Next-generation sequencing technologies determine 
the order of nucleotides in a single gene, genetic region, 
or across the whole genome (in the case of whole genome 
sequencing, WGS). Less costly than WGS is sequencing of 
the protein-coding genes in the genome (the exome, ap-
proximately 1% of the genome) in which variations are more 
likely to have phenotypic relevance. Sequencing of single 
nucleotide polymorphisms (SNPs, a single base pair mutation 
at a specific locus) can reveal variations of relevance for both 
understanding disease risk and pharmacogenomics. Although 
the cost of both genome and exome sequencing is falling at 
a rate exceeding Moore’s Law, access to even the $1,000 
exome is not widely available and is out of reach for most 
classroom use (2). For educational exercises, genotyping 
of students’ personal genomes typically involves collecting 
samples (typically saliva) and sending them to a commercial 
company (e.g., 23andMe), whose charges are within the 
budgets of many undergraduate and graduate students or 
their schools’ course budgets. More rarely, samples may 
be run on university-owned sequencers, potentially afford-
ing students “hands-on experience of detecting, analyzing 
and interpreting DNA variants to determine, for example, 
whether or not they are of clinical significance” (20). 
Currently, personal genomics companies are prohib-
ited from returning health-related genetic information (24). 
They are thus generally limiting themselves to reporting 
genetic ancestry, though they had provided disease-risk 
information in the past and may once again if they satisfy 
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concerns raised by the Food and Drug Administration. 
Companies like 23andMe do return raw data—SNPs—to 
those who submit samples, and individuals can use web-
based resources (e.g., Interpretome or Promethease) to 
analyze their own results at pharmacogenomic- or disease-
relevant loci. Astute students can thus obtain disease-risk 
and pharmacogenomics information as a result of current 
classroom sequencing exercises (15). Of scientific, and 
thus ethical concern, is the accuracy of data returned by 
personal genomics companies. During the time that they 
were returning disease-risk results, when the Government 
Accounting Office investigated the accuracy of companies’ 
reports, results for identical DNA samples sometimes 
varied between companies and sometimes conflicted with 
the medical status of the donor (16). 
In addition to having obvious implications for students’ 
reliance on test results, discussion of such conflicting and 
thus erroneous results can motivate classroom discussion 
of the ethical importance of reporting accurate information. 
Reporting individual or aggregate research results that fail 
to meet rigorous standards of validity risks undermining 
public confidence in scientific research. Discussion of the 
gravity of scientific misconduct, as well as the confidence-
eroding effects of failing to acknowledge the limitations of 
one’s study or of overstating the importance of research 
findings, can follow from initial discussion of what students’ 
personal genomic information can (and cannot) tell them 
and with what degree of confidence.
INFORMATION-RELATED ETHICAL ISSUES
Accurate or not, information presents three sets of 
ethical issues attending genetic testing/genomic sequencing 
in any context. The first concerns privacy and the reasons 
that individuals want to keep their information private. 
So-called privacy absolutists simply want to control ac-
cess to personal information about themselves, either in 
general or with regard to particular types of information 
or potential audiences for it. Students who share a lot 
about their dreams, worries, or weekend activities with 
friends in person or on Facebook, for example, may want 
to withhold such information from parents or others. Some 
privacy concerns relate not to control per se, but to the 
consequences of information’s disclosure. Health-related 
information is regarded as private not only because it may 
be relevant to personal, even intimate states of affairs and 
decision-making, but also because its discovery by others 
presents risks of stigmatization or discrimination. While 
social responses (stigmatization) cannot be legislated against, 
in 2008 the Genetic Information Nondiscrimination Act did 
prohibit discrimination in the United States by employers 
and health insurers on the basis of genetic information. Us-
ing such information in underwriting life, long-term care, 
automobile, or other insurance, however, is not prohibited. 
Insurers, who fear the purchase of substantial insurance 
by those whose genetic testing suggests they are accident 
prone or at increased risk of late-life dementia, may wish to 
deny such insurance or charge higher premiums. Whether 
particular classroom exercises present students with such 
information about themselves or not, educators should 
“practice preventive ethics” (7): they should anticipate issues 
that may arise imminently or, more likely, in the future, and 
prepare students to address them. In particular, students 
who may not anticipate future uses of health information 
should be cautioned that current self-disclosure of personal 
genetic information may make that information permanently 
accessible, for example if it is shared within social media or 
within social or family circles. Moreover, discussion of the 
protection of their own health information provides a con-
text to consider the short- and long-term risks to privacy 
of research participation.
The second constellation of ethical issues centers on 
the right to know personal information about oneself and 
the concomitant right not to know. It is hard to imagine 
students who would prefer to live in “blissful ignorance” 
of their PTC gene status; indeed, they likely already know 
whether they can taste bitterness in coffee or dark beer. 
Many health conditions and risks may be well-known to stu-
dents based on their family or personal medical history. For 
some, however, learning genetic information would not be 
welcome. Even pharmacogenomic information—seemingly 
benign or almost unqualifiedly helpful—could be unwelcome 
or could exacerbate underlying problems: while one student, 
struggling to treat his depression, might find it comforting 
to learn that genomic variation may account for his difficulty 
finding an anti-depressant that “works,” another student’s 
depression may be worsened by learning that his genotype 
will make it especially difficult to find effective treatment.
Finally, information that individuals believe they want 
may have unexpected and subtle psychosocial sequelae (8). 
Some young women who sought clinical genetic testing for 
breast cancer risk were nevertheless surprised to find that 
a positive result altered the way they viewed themselves 
and their futures, as well as their relationships. In qualitative 
studies, they reported feeling like “damaged goods”; feeling 
pressure to speed up dating, marriage, and reproductive 
plans; altering career paths; and feeling “out of synch” with 
their peers, like one BRCA+ woman who experienced am-
bivalence about her breasts while her friends were focused 
on more frivolous things like how clothing flattered their 
bustline (9, 10, 11, 27). The ethical implication of these se-
quelae is that educators have an obligation to practice pre-
ventive ethics to anticipate and mitigate the negative impact 
of learning personal genomic information. Consideration of 
the possible impact of learning genetic information should be 
a part of informed decision making and/or informed consent. 
Moreover, explicit classroom discussion of such potential 
impact may be used to introduce discussion of researchers’ 
obligations to identify, mitigate, and disclose risks of their 
research, including risks to human participants. 
Even with regard to less weighty genetic informa-
tion—specifically the sort of genetic ancestry information 
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currently available from personal genomics companies—
upon receiving results, students have expressed surprise 
and not uniformly positive reactions. In 2005, Samuel 
Richards used genetic testing in his Pennsylvania State 
University sociology class to demonstrate “to students 
how complex race and ethnicity are” (5). His colleague 
in anthropology and genetics, Mark Shriver, took cheek 
swab samples from 100 class volunteers for a test Shriver 
developed with partners at DNAPrint Genomics to 
measure genetic admixture in populations (because of 
the relevance of continental ancestry and admixture for 
clinical drug trials). Richards believed that if DNA results 
indicated continental ancestry differing from students’ 
initial beliefs about their race, they might be more open 
to differences and have deeper discussions about race. In-
stead the results seemed to reinforce racially constructed 
categories (12), with one student saying, for example, “I 
am 48 percent white—genetically … but not culturally. 
And the fact that I’m black is more important … It’s who 
I’m comfortable with. … Just because I found out I’m 
white, I’m not going to act white. I’m very proud of my 
black side” (5). The New York Times headline reporting 
the study, “DNA Tells Students They Aren’t Who They 
Thought,” suggests how DNA findings can disrupt indi-
vidual identity and familial understandings of ancestry, 
cultural origins, and relationships (5). For some, DNA 
evidence of ancestry admixture, for example between 
those of European and African descent, may raise previ-
ously unconfronted questions of sexual relations—con-
sensual or not, recent or distant—between individuals of 
different culturally-defined races. Educators using genetic 
ancestry information need to recognize and prepare to 
address such intrafamilial or historical questions (e.g., the 
legacy of rape of African-American slaves by European-
American slave owners, or miscegenation laws). 
Moreover, some social benefits attach to having a par-
ticular ethnic or racial identity, e.g., eligibility for scholarships 
or organization membership, or entitlement to settlements 
from legal disputes or to particular revenue streams (e.g., 
receipt of revenues from businesses run by Native American 
nations or tribes). It remains to be seen how a scholarship 
committee (or students themselves) might interpret the eli-
gibility of a student who has always self-identified as Black or 
African-American, but whose classroom DNA test reveals 
him to be, for example, 62 percent European. When tribal 
membership—usually established on the basis of tribal group 
relations, a tribal land-base, and cultural continuity—is 
contested, individuals or tribes may employ DNA analysis, 
though thus far its legal status is not established and genetic 
markers usually cannot identify tribal membership (6, 22). 
Both science and law, however, evolve. 
Finally, it is instructive to note that the results of DNA-
testing of Richards’ students were stored in Shriver’s re-
search database. This arrangement raises the usual research 
ethics questions regarding informed consent, consent to 
subsequent research use of the results, whether and how 
individuals can withdraw their results, third-party access to 
results (with or without court order), and whether students 
will be informed of any findings (individual or aggregate) of 
future research employing their results. 
TESTING IN THE CLASSROOM CONTEXT: EDUCATION, 
RESEARCH, AND THE ROLE OF INSTITUTIONAL REVIEW 
BOARDS
Testing/sequencing in the classroom presents a special 
set of issues because of the opportunity for students to feel 
pressured—by peers or faculty—to acquire genetic informa-
tion about themselves that they do not want. While there 
is a dearth of empirical data regarding whether students 
actually feel such pressures (20), students have recognized 
that the opportunity to receive personal genome sequenc-
ing at no cost to them may constitute a substantial benefit. 
Whether receiving a ($100+) service that most admit they 
would not get if they were paying for it themselves (20) 
constitutes the equivalent of “excessive compensation” that 
would be prohibited by an institutional review board (IRB) in 
the research context is an open question that likely depends 
on contextual factors surrounding individual students and 
courses (e.g., whether it is required or elective). Class-
room discussion of broader ethical questions of pressure 
to participate in research, informed autonomous decision 
making, and appropriate levels of compensation of research 
participants may be pursued when presenting opportunities 
for personal genome testing. “Empirical evidence address-
ing whether students are making independent, informed 
decisions about analyzing their own personal genomes and 
whether efforts to help students make informed decisions 
are successful would shed valuable light on a major ethical 
concern surrounding personal genomes in the classroom” 
(20). In the absence of such data, given the empirical data 
that are reported on student uptake of offers of personal 
genomic testing and their positive responses regarding its 
educational impact, it is reasonable to assume that while a 
substantial majority of students at all levels may be interested 
in personal testing, a minority may not. Care must be taken 
when incorporating personal genomic testing into course 
curricula, as some students may not only feel pressured to 
participate, but also worry that opting out, if permitted, 
may indicate that they know or suspect something about 
themselves that they do not want to confirm or enable 
others to learn. 
Provision of alternate, non-personal samples for stu-
dents to use for class exercises—particularly if fellow stu-
dents and faculty members remain uninformed of a student’s 
choice of the alternative—may maximally shield students 
from pressure. In the case of testing that yields raw SNP 
data, students may be invited to submit saliva samples on 
their own to a designated personal genomics company. The 
company should have its own consent process that explains 
privacy protection measures. Students may then submit their 
own data for inclusion in the class data set, or may pick up 
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one of the alternate non-personal samples or testing reports 
(depending on the nature of the planned exercises) to use 
for class exercises.
Even if it is not a research activity, educational use of 
personal testing/sequencing might be helpfully reviewed by an 
IRB or other body experienced in identifying and mitigating 
risks to privacy and pressure to participate. When research 
is conducted on the educational process employing personal 
genome information, it can be complicated to determine 
whether the activity constitutes research involving human 
subjects that should be reviewed by an IRB or whether it 
qualifies for exemption under 45 CFR 46.101(b)(1) because 
it is “conducted in established or commonly accepted educa-
tional settings, involving normal educational practices, such 
as (i) research on regular and special education instructional 
strategies, or (ii) research on the effectiveness of or the 
comparison among instructional techniques, curricula, or 
classroom management methods” (23). Particularly when 
the instructional technique under study involves genomic 
testing/sequencing, something that in a non-educational 
context would require the informed consent of the person 
tested, it seems wise to consult an IRB about the status of 
the activity. Especially if a commercial company employing 
its own consent process is not utilized but testing is done 
“in house” or classroom, consideration should be given to 
obtaining students’ informed consent, and this process may 
be used as an opportunity to teach this fundamental doctrine 
of research ethics. Even if informed consent is not considered 
necessary, enabling students to make an informed decision 
about participating is ethically required. 
The process of facilitating informed decision making has 
been studied by one group at the Icahn School of Medicine at 
Mount Sinai where instructors designed a 26-hour introduc-
tory course discussing ethical and psychosocial implications 
of genetic testing/sequencing, including familial and reproduc-
tive implications, as well as the scientific and technological 
foundation for analyzing and interpreting WGS results, and 
the limitations thereof. Students were also told that if they 
chose to work with their own WGS data later in the course 
sequence, they could exclude data they did not want to see. 
Following completion of the introductory course, there was 
a shift from 47% of students saying that they were able to 
make an informed choice about analyzing their own genomes 
to 84%. Those affirming that they “knew the risks” similarly 
rose from 47% to 90%, and fewer students were concerned 
about the consequences of others learning their genetic 
information and about their privacy. An increased number 
expressed belief that using their own genomic information 
would have educational benefits not afforded by using others’ 
results (22). Despite its employing a small sample (n = 19) 
of self-selected, motivated, genetics-focused students, this 
study suggests that students’ decision making about using 
their own genomic information can be enhanced. Further 
study would be required to determine whether a 26-hour 
course is necessary, or which components of it were most 
important to their enhanced decision-making ability.
Finally, the very idea of using personal genomic test-
ing as a pedagogical tool may be usefully discussed with 
students as a way of introducing broader questions about 
the use of resources (in education and, by analogy, in re-
search) and of agenda-setting in science. Despite substantial 
interest among educators in employing personal genomic 
testing to enhance learning, one study found that taking a 
core genetics course substantially reduced students’ belief 
that working with their own genomic information would 
enhance their learning more than using others’ (from 67% 
pre- to 45% post-course) and lowered their perceptions 
of the usefulness of genomic information for themselves, 
physicians, and patients (17). Nevertheless, roughly the 
same proportion (57% pre- and 55% post-) remained inter-
ested in learning their personal genomic information, with 
general curiosity being the primary reason given before and 
after the course (96% and 94%). In light of these findings, 
instructors and students might have productive discussions 
of the appropriateness of employing expensive genomic 
testing/sequencing technologies to satisfy curiosity or 
to compete for enrollment against other courses using 
“cutting-edge technology.” Instructors may draw analogies 
to broader issues in research ethics such as the multiple 
influences on determination of which research questions 
are worth pursuing and investigators’ responsibilities to 
help the public interpret and assign value to findings.
CONCLUSION
Careful consideration of how to enable students to 
make informed decisions about obtaining and using their 
personal genomic information in educational contexts is 
incumbent upon educators. In addition, instructors should 
anticipate and take measures to mitigate risks to privacy 
and potential negative psychosocial sequelae. Just as cur-
rently unknown pleiotropy can result in seemingly innocuous 
genetic information having health relevance in the future, 
what instructors do not know about their students’ per-
sonal circumstances and preferences may render seemingly 
innocuous exercises or information problematic for some 
students. These risks should be neither overblown nor 
ignored. With thoughtful planning, many can be mitigated. 
Moreover, explicit discussion of these ethical considerations 
provides an opportunity to enhance students’ research eth-
ics skills by encouraging consideration of underlying ethical 
values and issues pertinent to multiple research contexts.
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